BLISOVI FE 1.5/30
Blisovi Fe 1.5/30(norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets*)1.5 mg/0.03 mg*Ferrous Fumarate Tablets are not USP for dissolution
Approved
Approval ID
a0ba9371-46c5-4291-8409-491911e255ab
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 14, 2023
Manufacturers
FDA
Lupin Pharmaceuticals, Inc.
DUNS: 089153071
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norethindrone acetate and ethinyl estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68180-866
Application NumberANDA201585
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone acetate and ethinyl estradiol
Product Specifications
Effective DateDecember 14, 2023
FDA Product Classification